Annual Current Ratio
5.57
-2.35-29.67%
31 December 2023
Summary:
Enlivex Therapeutics annual current ratio is currently 5.57, with the most recent change of -2.35 (-29.67%) on 31 December 2023. During the last 3 years, it has fallen by -3.15 (-36.12%). ENLV annual current ratio is now -69.60% below its all-time high of 18.32, reached on 31 December 2021.ENLV Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
10.06
+2.20+27.99%
30 June 2024
Summary:
Enlivex Therapeutics quarterly current ratio is currently 10.06, with the most recent change of +2.20 (+27.99%) on 30 June 2024. Over the past year, it has increased by +2.72 (+37.06%). ENLV quarterly current ratio is now -66.56% below its all-time high of 30.08, reached on 30 September 2014.ENLV Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | +37.1% |
| 3 y3 years | -36.1% | -47.3% |
| 5 y5 years | -38.7% | +153.4% |
ENLV Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -69.6% | at low | -47.3% | +80.6% |
| 5 y | 5 years | -69.6% | +102.5% | -50.4% | +265.8% |
| alltime | all time | -69.6% | +188.6% | -66.6% | +341.2% |
Enlivex Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | 10.06(+28.0%) |
| Mar 2024 | - | 7.86(+41.1%) |
| Dec 2023 | 5.57(-29.7%) | 5.57(-24.1%) |
| Sept 2023 | - | 7.34(+19.0%) |
| June 2023 | - | 6.17(-10.4%) |
| Mar 2023 | - | 6.89(-13.0%) |
| Dec 2022 | 7.92(-56.8%) | 7.92(-39.4%) |
| Sept 2022 | - | 13.08(-15.3%) |
| June 2022 | - | 15.44(+11.8%) |
| Mar 2022 | - | 13.81(-24.6%) |
| Dec 2021 | 18.32(+110.1%) | 18.32(-4.0%) |
| Sept 2021 | - | 19.08(-6.0%) |
| June 2021 | - | 20.29(+6.2%) |
| Mar 2021 | - | 19.11(+119.2%) |
| Dec 2020 | 8.72(+217.1%) | 8.72(+20.6%) |
| Sept 2020 | - | 7.23(+5.5%) |
| June 2020 | - | 6.85(-0.1%) |
| Mar 2020 | - | 6.86(+149.5%) |
| Dec 2019 | 2.75 | 2.75(-30.7%) |
| Sept 2019 | - | 3.97(+5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | 3.77(-0.5%) |
| Mar 2019 | - | 3.79(-58.3%) |
| Dec 2018 | 9.09(+15.5%) | 9.09(-23.2%) |
| June 2018 | - | 11.83(+50.3%) |
| Dec 2017 | 7.87(+44.1%) | 7.87(-1.4%) |
| Sept 2017 | - | 7.98(+14.7%) |
| June 2017 | - | 6.96(+44.4%) |
| Mar 2017 | - | 4.82(-11.7%) |
| Dec 2016 | 5.46(-32.7%) | 5.46(-17.8%) |
| Sept 2016 | - | 6.64(-42.0%) |
| June 2016 | - | 11.45(+11.5%) |
| Mar 2016 | - | 10.27(+26.6%) |
| Dec 2015 | 8.11(-43.8%) | 8.11(-40.0%) |
| Sept 2015 | - | 13.51(-12.6%) |
| June 2015 | - | 15.45(-9.7%) |
| Mar 2015 | - | 17.11(+18.7%) |
| Dec 2014 | 14.42(+532.5%) | 14.42(-52.1%) |
| Sept 2014 | - | 30.08(+389.9%) |
| June 2014 | - | 6.14(+169.3%) |
| Dec 2013 | 2.28(+18.1%) | 2.28 |
| Dec 2012 | 1.93 | - |
FAQ
- What is Enlivex Therapeutics annual current ratio?
- What is the all time high annual current ratio for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual current ratio year-on-year change?
- What is Enlivex Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly current ratio year-on-year change?
What is Enlivex Therapeutics annual current ratio?
The current annual current ratio of ENLV is 5.57
What is the all time high annual current ratio for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual current ratio is 18.32
What is Enlivex Therapeutics annual current ratio year-on-year change?
Over the past year, ENLV annual current ratio has changed by -2.35 (-29.67%)
What is Enlivex Therapeutics quarterly current ratio?
The current quarterly current ratio of ENLV is 10.06
What is the all time high quarterly current ratio for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly current ratio is 30.08
What is Enlivex Therapeutics quarterly current ratio year-on-year change?
Over the past year, ENLV quarterly current ratio has changed by +2.72 (+37.06%)